MedTrace Logo

To Demonstrate the Relative Bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fasted Conditions

NCT00913783 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2017-03-28

No results posted yet for this study

Summary

To demonstrate the relative bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride capsules under fasted conditions.

Conditions

Interventions

DRUG

Clomipramine Hydrochloride 25 mg Capsules (Geneva Pharmaceuticals)

DRUG

Anafranil Clomipramine Hydrochloride 25 mg Capsules (Basel)

Sponsors & Collaborators

Principal Investigators

  • Richard Lalonde, Pharm.D. · Phoenix International Life Science Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1992-11-30
Primary Completion
1992-12-31
Completion
1992-12-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00913783 on ClinicalTrials.gov